The Great Pharmaceutical Pivot: Navigating Strategy, IP Valuation, and Portfolio Resilience in the Post-Blockbuster Era
Introduction: The Structural Collapse of the Primary Care Model The pharmaceutical industry is currently navigating a seismic shift, often described […]




